Ningning Hou

School of Clinical Medicine

H指数:30

被引数:3,038

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Homeobox genes in endocrine tumorigenesis: mechanisms, tumor microenvironment interaction, and therapeutic potential

内分泌肿瘤发生中的同源盒基因：机制、肿瘤微环境相互作用及治疗潜力

Medical Oncology

IF3.5

2026-08-220

PRE

12,13-diHOME ameliorates MASLD by regulating Sestrin2-mediated AMPK/ULK1/Lipophagy in obese mice

Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

IF0

2026-02-050

PRE

Epidemiology of metabolic dysfunction-associated steatotic liver disease -related liver diseases: 1990-2021 and projections to 2045

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

IF1.8

2026-02-011

PRE

Association between cardiometabolic index and thyroid function: insights from NHANES

心代谢指数与甲状腺功能之间的关联：NHANES的见解

Hormones-International Journal of Endocrinology and Metabolism

IF2.5

2025-12-011

PRE

Global burden of rheumatic vs non-rheumatic valvular heart disease, 1990–2021: a systematic analysis of the global burden of disease study

1990—2021年风湿性与非风湿性瓣膜性心脏病的全球负担比较：一项全球疾病负担研究的系统分析

Clinical Rheumatology

IF2.8

2025-10-130

PRE

The role and therapeutic potential of exosome-mediated microRNAs regulatory networks in diabetic kidney disease

外泌体介导的微小RNA调控网络在糖尿病肾病中的作用及治疗潜力

Molecular Biology Reports

IF2.8

2025-09-130

PRE

衰老相关肥胖：揭示线粒体和代谢功能障碍

Current Nutrition Reports

IF5.5

2025-07-240

PRE

Global epidemiology of type 1 diabetes in youth: 1990–2021 and projections to 2045

全球儿童1型糖尿病的流行病学：1990–2021年及2045年预测

Endocrine

IF2.9

2025-07-190

PRE

Therapeutic Potential of Ginsenosides in the Treatment of Endocrine Diseases: Roles and Mechanisms

人参皂苷在内分泌疾病治疗中的潜力：作用与机制

Phytotherapy Research

IF6.3

2025-07-070

PRE

High-performance photocurable resins derived from small-molecule naphthalene-type epoxides: enabled by biphenyl main and side-chain editing

源自小分子萘型环氧树脂的高性能光固化树脂：通过联苯主链和侧链修饰实现

POLYMER

IF4.5

2025-06-010

PRE

Updated Insights on Childhood Diabetes Epidemiology 2019-2021 and Projections to 2045

JAMA PEDIATRICS

IF18

2025-02-010

PRE

Global burden and future trends of metabolic dysfunction-associated Steatotic liver disease: 1990-2021 to 2045

代谢功能障碍相关脂肪性肝病的全球负担和未来趋势: 1990-2021 2045年

ANNALS OF HEPATOLOGY

IF4.4

2025-01-010

OAAI

Intestinal glucagon-like peptide-1 in hypoglycemic counterregulation for type 1 diabetes management

WORLD JOURNAL OF DIABETES

IF4.6

2024-12-150

PRE

Empagliflozin alleviates obesity-related cardiac dysfunction via the activation of SIRT3-mediated autophagosome formation

LIPIDS IN HEALTH AND DISEASE

IF4.2

2024-09-274

OAAI

The complex link between the gut microbiome and obesity-associated metabolic disorders: Mechanisms and therapeutic opportunities

肠道微生物组与肥胖相关代谢紊乱之间的复杂联系: 机制和治疗机会

HELIYON

IF3.6

2024-09-014

OAAI

Sestrin2 knockout exacerbates high-fat diet induced metabolic disorders and complications in female mice

NUTRITION & METABOLISM

IF4.1

2024-08-021

OAAI

Emerging therapeutic landscape: Incretin agonists in chronic kidney disease management

LIFE SCIENCES

IF5.1

2024-08-010

PRE

Metagenomic and metabolomic analysis showing the adverse risk-benefit trade-off of the ketogenic diet

LIPIDS IN HEALTH AND DISEASE

IF4.2

2024-06-293

OAAI

Editorial: The link between metabolic syndrome and chronic kidney disease: focus on diagnosis and therapeutics - volume II

FRONTIERS IN ENDOCRINOLOGY

IF4.6

2024-06-130

OAAI

The impact of the senescent microenvironment on tumorigenesis: Insights for cancer therapy

衰老微环境对肿瘤发生的影响: 癌症治疗的见解

AGING CELL

IF7.1

2024-04-220

OAAI

Ningning Hou

个人简介

教育背景

工作经历

荣誉奖项

研究方向